Skip to main content

Peritoneal Fluid Analysis

  • Chapter
  • First Online:
Book cover Liver Diseases
  • 2867 Accesses

Abstract

The abnormal accumulation of peritoneal fluid in the abdomen is a frequent complication in patients with cirrhotic and non-cirrhotic portal hypertension which is defined as ascites whose appearance heralds worsening of prognosis in such chronic diseases of the liver. Ascites can be also associated with acute liver failure, hepatic and extra-hepatic malignancies, infections (among them tuberculosis), pancreatitis, malnutrition or malabsorption or other rare inflammatory conditions. Therefore, peritoneal fluid analysis is mandatory to differentiate these clinical conditions in order to guide the best clinical management and treatment. This chapter summarizes the most important principles of peritoneal fluid analysis to best differentiate the etiological diagnosis of ascites.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Runyon BA, AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: update 2012. Hepatology. 2013;57(4):1651–3.

    Article  Google Scholar 

  2. European Association for the Study of the Liver. EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–60.

    Article  Google Scholar 

  3. Wong F. Management of ascites in cirrhosis. J Gastroenterol Hepatol. 2012;27(1):11–20.

    Article  CAS  Google Scholar 

  4. De Gottardi A, Thévenot T, Spahr L, et al. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. Clin Gastroenterol Hepatol. 2009;7(8):906–9.

    Article  Google Scholar 

  5. Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference. Under the auspices of the Italian Association for the Study of Liver Diseases (AISF) and the Italian Society of Internal Medicine (SIMI). Dig Liver Dis. 2016;48:455–67.

    Google Scholar 

  6. Uddin MS, Hoque MI, Islam MB, et al. Serum-ascites albumin gradient in differential diagnosis of ascites. Mymensingh Med J. 2013;22(4):748–54.

    CAS  PubMed  Google Scholar 

  7. Kim JJ, Tsukamoto MM, Mathur AK. Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis. Am J Gastroenterol. 2014;109(9):1436–42.

    Article  CAS  Google Scholar 

  8. Cavazzoni E, Bugiantella W, Graziosi L, et al. Malignant ascites: pathophysiology and treatment. Int J Clin Oncol. 2013;18:1–9.

    Article  Google Scholar 

  9. Farias AQ, Silvestre OM, Garcia-Tsao G, et al. Serum B-type natriuretic peptide in the initial workup of patients with new onset ascites: a diagnostic accuracy study. Hepatology. 2014;59(3):1043–51.

    Article  CAS  Google Scholar 

  10. Guillaume M, Robic MA, Péron JM, et al. Clinical characteristics and outcome of cirrhotic patients with high protein concentrations in ascites: a prospective study. Eur J Gastroenterol Hepatol. 2016;28(11):1268–74.

    Article  CAS  Google Scholar 

  11. Riker D, Goba D. Ovarian mass, pleural effusion, and ascites: revisiting Meigs syndrome. J Bronchol Interv Pulmonol. 2013;20(1):48–51.

    Article  Google Scholar 

  12. Field Z, Zori A, Khullar V. Malignant peritoneal mesothelioma presenting as mucinous ascites. ACG Case Rep J. 2018;5:e23.

    Article  Google Scholar 

  13. Chauhan A, Patodi N, Ahmed M. A rare cause of ascites: pseudomyxoma peritonei and a review of the literature. Clin Case Rep. 2015;3(3):156–9.

    Article  Google Scholar 

  14. Khalid S, Asad-Ur-Rahman F, Abbass A, et al. Myxedema ascites: a rare presentation of uncontrolled hypothyroidism. Cureus. 2016;8(12):e912.

    PubMed  PubMed Central  Google Scholar 

  15. Karlapudi S, Hinohara T, Clements J, et al. Therapeutic challenges of pancreatic ascites and the role of endoscopic pancreatic stenting. BMJ Case Rep. 2014; https://doi.org/10.1136/bcr-2014-204774.

    Google Scholar 

  16. Lizaola B, Bonder A, Trivedi HD, et al. Review article: The diagnostic approach and current management of chylous ascites. Aliment Pharmacol Ther. 2017;46(9):816–24.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vincenzo La Mura .

Editor information

Editors and Affiliations

Exercises

Exercises

1.1 Case 1

Sixty-eight years old man, recent 5 kg weight gain and abdominal distension. In medical history: diabetes mellitus for 3 years, hypothyroidism treated, no history of liver disease.

  • Blood Tests: AST 87 U/L; ALT 56 U/L; total bilirubin 1.4 mg/dL; albumin 3 g/dL; pCHE 1388 U/L, INR 1.31, creatinine 0.65 mg/dL. Anti HCV Ab positive, HCVRNA positive, normal TSH test.

  • Abdominal US: Ascitic fluid, small-sized liver, no focal lesions, portal vein 17 mm, splenomegaly (15 cm).

  • Diagnostic paracentesis:

    • Clear fluid

    • Liquid analysis: WBC 110/mm3, albumin 0.8 g/dL, total protein 1.1 g/dL, amylase 38 mg/dL, LDH 73 U/L, glucose 10 mg/dL ➔ SAAG 2.2 g/dL

    • Aerobic and anaerobic fluid culture: negative

    Diagnosis: ascites in previously unknown HCV-related cirrhosis.

1.2 Case 2

Fifty-one years old woman, abdominal distension and pain. In medical history: breast cancer 8 years before (surgery, radiotherapy and chemotherapy).

  • Blood Tests: AST 14 U/L; ALT 12 U/L; total bilirubin 0.2 mg/dL; albumin 3.9 g/dL; pCHE 6974 U/L, INR 1.03, creatinine 0.76 mg/dL. Anti HCV Ab negative; HBsAg negative, CA 15.3 1287 U/mL (<34 U/mL).

  • Abdominal US: Ascitic fluid, regular liver, no focal lesions, portal vein 9 mm, spleen regular.

  • Total body CT scan: lymphadenomegaly (chest and abdomen, diameter max 4 cm) abundant ascites, suspected peritoneal carcinomatosis

  • Diagnostic paracentesis:

    • Blood fluid

    • Liquid analysis: WBC 192/mm3, albumin 3.1 g/dL, amylase 47 mg/dL, LDH 106 U/L ➔ SAAG 0.8 g/dL

    • Aerobic and anaerobic fluid culture: negative

    • Cytology: positive for atypical cell (suspected malignant cells)

    Diagnosis: malignant ascites in metastatic breast cancer.

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tosetti, G., La Mura, V. (2020). Peritoneal Fluid Analysis. In: Radu-Ionita, F., Pyrsopoulos, N., Jinga, M., Tintoiu, I., Sun, Z., Bontas, E. (eds) Liver Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-24432-3_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-24432-3_37

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-24431-6

  • Online ISBN: 978-3-030-24432-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics